Email Updates

Search form

You are here

Will bNAbs Yield a One Size Fits all HIV Vaccine?

Include in
Media Coverage

It has been 21 years now and still ongoing—research for the HIV vaccine. Researchers are now focusing on identifying a particular antibody type that can disarm the virus, by using the broadly neutralizing antibodies (bNAbs).

October 25, 2018
New Vision